Revue du Rhumatisme

Journal

Overview
Identity

Publication Venue For

Manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational study. 89:65-71. 2022

Pop a pill or give myself a shot? Patient perspectives of disease-modifying anti-rheumatic drug choice for rheumatoid arthritis. 88:362-368. 2021

Important determinants of the patient choice between TNF- vs. non-TNF biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA). 88:49-55. 2021

Efficacy of burosumab in a case of tumor-induced osteomalacia. 87:300-302. 2020

The risk of Gougerot-Sjogren's syndrome in older adults with gout: A Medicare claims study. 87:110-115. 2020

Comparaison du certolizumab pegol versus adalimumab : résultats d'efficacité et de tolérance à 2 ans d'une étude comparative directe de supériorité, en aveugle pour les investigateurs. 83:A125-A126. 2016

Frequency of CYP2C9 polymorphisms in Polynesians and potential relevance for the treatment of gout by benzbromarone. 81:159-163. 2014

Effect of resistance exercise on bone mineral density in premenopausal women. 76:439-447. 2009

Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: Two cases. 76:292-296. 2009

Is it fibromyalgia? Is it lupus? Too much or not enough: Comments related to women referred to a tertiary care academic rheumatology research and treatment center. 69:850-854. 2002

International Standard Serial Number (issn)

1169-8330